Zitholide 250 Tablet is a combination antibiotic formulation containing Azithromycin 250 mg and Lactic Acid Bacillus 60 million spores, designed for the effective treatment of various bacterial infections while maintaining gastrointestinal flora balance. Azithromycin, a macrolide antibiotic, exhibits broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria by inhibiting bacterial protein synthesis, thereby halting bacterial growth and proliferation. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted infections. The inclusion of Lactic Acid Bacillus, a probiotic, helps restore and maintain the natural intestinal microflora, which may be disrupted during antibiotic therapy, reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. Zitholide 250 is typically administered orally, with dosage and duration tailored according to the severity and type of infection, as well as patient-specific factors. Caution is advised in patients with known hypersensitivity to macrolides or probiotics. Common side effects may include gastrointestinal discomfort, nausea, or mild diarrhea. This combination therapy offers an effective approach to managing bacterial infections while supporting gut health, enhancing patient compliance and therapeutic outcomes. Always use under medical supervision.